11 Vedolizumab induction therapy for patients with Crohn's disease and prior anti-tumour necrosis factor antagonist failure: a randomised, placebo-controlled, double-blind, multicentre trial
Year: 2013
Type: article
Study design: Clinical Trial
Source: Journal of Crohn s and Colitis
Authors: B. Sands, B. Feagan, P. Rutgeerts, J.-F. Colombel, W. Sandborn, R. Sy, G. D'Haens, S. Ben-Horin, J. Xu, I. Fox, A. Parikh, C. Milch, S. Hanauer
Institutions: The Royal Melbourne Hospital, Icahn School of Medicine at Mount Sinai, Western University, Commonwealth Scientific and Industrial Research Organisation, Robarts Research Institute, KU Leuven, Hôpital Claude Huriez, UC San Diego Health System, University of California San Diego, University of Ottawa, Amsterdam UMC Location University of Amsterdam, University of Amsterdam, Sheba Medical Center, Takeda Oncology (United States), University of Chicago Medical Center
Language: English
Topic: Inflammatory Bowel Disease
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1997443433